SCHEMBL17607342

SCHEMBL17607342

CCCCCB(O)OC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.39
GPR84 Q9NQS5 7/20 0.38
PPARG P37231 7/20 0.38
PPARD Q03181 7/20 0.38
PPARA Q07869 7/20 0.38
HDAC11 Q96DB2 5/20 0.38
TSHR P16473 4/20 0.38
PTPN1 P18031 3/20 0.38
ALDH1A1 P00352 2/20 0.38
TLR2 O60603 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
FABP4 P15090 2/20 0.38
KMT2A Q03164 2/20 0.38
SLC22A6 Q4U2R8 1/20 0.38
SLC22A8 Q8TCC7 1/20 0.38
MEN1 O00255 1/20 0.38
ESR1 P03372 1/20 0.38
ALOX15 P16050 1/20 0.38
PDE4A P27815 1/20 0.38
PDE3A Q14432 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17287861 0.77
SCHEMBL16521392 0.75 ANPEP (0.42) TSHRALDH1A1KMT2AMEN1HSD17B10
SCHEMBL1726025 0.74 ANPEP (0.46) AKR1B1TSHRALDH1A1KMT2AMEN1
SCHEMBL8522636 0.71 ANPEP (0.39) AKR1B1TSHRANPEPCES2CES1
SCHEMBL10584179 0.70
SCHEMBL9561943 0.70
SCHEMBL21154909 0.68 ANPEP (0.40) TSHRALDH1A1KMT2AMEN1HSD17B10
Hexane SCHEMBL27816104 0.68 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
Hexane SCHEMBL7024948 0.68 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
Hexane SCHEMBL9670901 0.66 AKR1B1 (0.65) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111629746-B Charge switchable polymer depot for glucose-triggered insulin delivery with ultra-fast response 北卡罗来纳州立大学 2024-04-16 CN disclosed
US-11813352-B2 Charge-switchable polymeric depot for glucose-triggered insulin delivery with ultrafast response NORTH CAROLINA STATE UNIVERSITY (US) 2023-11-14 US disclosed
US-20200360269-A1 CHARGE-SWITCHABLE POLYMERIC DEPOT FOR GLUCOSE-TRIGGERED INSULIN DELIVERY WITH ULTRAFAST RESPONSE NORTH CAROLINA STATE UNIVERSITY 2020-11-19 US disclosed
EP-3713594-A1 CHARGE-SWITCHABLE POLYMERIC DEPOT FOR GLUCOSE-TRIGGERED INSULIN DELIVERY WITH ULTRAFAST RESPONSE North Carolina State University (US) 2020-09-30 EP disclosed
CN-111629746-A Charge switchable polymer depot for glucose triggered insulin delivery with ultra-fast response 北卡罗来纳州立大学 2020-09-04 CN disclosed
WO-2019104006-A1 CHARGE-SWITCHABLE POLYMERIC DEPOT FOR GLUCOSE-TRIGGERED INSULIN DELIVERY WITH ULTRAFAST RESPONSE NORTH CAROLINA STATE UNIVERSITY (US) 2019-05-31 WO disclosed
US-10180435-B2 Method of surface modification by proteins for analyte preconcentration for desorption-ionization mass spectrometry techniques and for immunochemical assays MIKROBIOLOGICKY USTAV AV CR, V.V.I. 2019-01-15 US disclosed
EP-3194943-B1 METHOD OF SURFACE MODIFICATION BY PROTEINS FOR ANALYTE PRECONCENTRATION FOR DESORPTION-IONIZATION MASS SPECTROMETRY TECHNIQUES AND FOR IMMUNOCHEMICAL ASSAYS NOVAK PETR (CZ) 2018-09-12 EP disclosed
US-20170242030-A1 Method of Surface Modification by Proteins for Analyte Preconcentration for Desorption-Ionization Mass Spectrometry Techniques and for Immunochemical Assays MIKROBIOLOGICKY USTAV AV CR, V.V.I. 2017-08-24 US disclosed
EP-3194943-A1 METHOD OF SURFACE MODIFICATION BY PROTEINS FOR ANALYTE PRECONCENTRATION FOR DESORPTION-IONIZATION MASS SPECTROMETRY TECHNIQUES AND FOR IMMUNOCHEMICAL ASSAYS Novak, Petr (CZ) 2017-07-26 EP disclosed
WO-2016041531-A1 METHOD OF SURFACE MODIFICATION BY PROTEINS FOR ANALYTE PRECONCENTRATION FOR DESORPTION-IONIZATION MASS SPECTROMETRY TECHNIQUES AND FOR IMMUNOCHEMICAL ASSAYS NOVAK PETR (CZ) 2016-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11813352-B2 Charge-switchable polymeric depot for glucose-triggered insulin delivery with ultrafast response IAPP, GPR119, INSR AKR1B1 4759/4885GPR84 2779/4885PPARG 801/4885
US-20200360269-A1 CHARGE-SWITCHABLE POLYMERIC DEPOT FOR GLUCOSE-TRIGGERED INSULIN DELIVERY WITH ULTRAFAST RESPONSE IAPP, GPR119, INSR AKR1B1 4759/4885GPR84 2779/4885PPARG 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.